HEADER IMMUNE SYSTEM 30-AUG-07 2Z80 TITLE CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY BINDING OF A TITLE 2 TRI-ACYLATED LIPOPEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TOLL-LIKE RECEPTOR 2, VARIABLE LYMPHOCYTE RECEPTOR B; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: TLR2, UNP RESIDUES 1-284(HUMAN), VLRB.61, UNP RESIDUES 136- COMPND 5 199(INSHORE HAGFISH); COMPND 6 SYNONYM: TOLL/INTERLEUKIN-1 RECEPTOR-LIKE PROTEIN 4, CD282 ANTIGEN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, EPTATRETUS BURGERI; SOURCE 3 ORGANISM_COMMON: HUMAN, INSHORE HAGFISH; SOURCE 4 ORGANISM_TAXID: 9606, 7764; SOURCE 5 STRAIN: ,; SOURCE 6 GENE: TLR2, TIL4, VLRB; SOURCE 7 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 8 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: HI-5; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PVL1393 KEYWDS TLR2, LIPOPEPTIDE, INNATE IMMUNITY, GLYCOPROTEIN, IMMUNE RESPONSE, KEYWDS 2 INFLAMMATORY RESPONSE, LEUCINE-RICH REPEAT, MEMBRANE, RECEPTOR, KEYWDS 3 TRANSMEMBRANE, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.O.LEE,M.S.JIN,S.E.KIM,J.Y.HEO REVDAT 6 29-JUL-20 2Z80 1 COMPND SEQADV HETNAM LINK REVDAT 5 16-AUG-17 2Z80 1 SOURCE REMARK REVDAT 4 13-JUL-11 2Z80 1 VERSN REVDAT 3 24-FEB-09 2Z80 1 VERSN REVDAT 2 02-OCT-07 2Z80 1 JRNL REVDAT 1 25-SEP-07 2Z80 0 JRNL AUTH M.S.JIN,S.E.KIM,J.Y.HEO,M.E.LEE,H.M.KIM,S.G.PAIK,H.LEE, JRNL AUTH 2 J.O.LEE JRNL TITL CRYSTAL STRUCTURE OF THE TLR1-TLR2 HETERODIMER INDUCED BY JRNL TITL 2 BINDING OF A TRI-ACYLATED LIPOPEPTIDE JRNL REF CELL(CAMBRIDGE,MASS.) V. 130 1071 2007 JRNL REFN ISSN 0092-8674 JRNL PMID 17889651 JRNL DOI 10.1016/J.CELL.2007.09.008 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.2 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 526063.370 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.7 REMARK 3 NUMBER OF REFLECTIONS : 57446 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.220 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2907 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 89.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8259 REMARK 3 BIN R VALUE (WORKING SET) : 0.2120 REMARK 3 BIN FREE R VALUE : 0.2600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 472 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5069 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 14 REMARK 3 SOLVENT ATOMS : 263 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 10.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 15.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.68000 REMARK 3 B22 (A**2) : -0.34000 REMARK 3 B33 (A**2) : -0.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.15000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : -0.0 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.26 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.06 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.40 REMARK 3 BSOL : 35.27 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED REMARK 4 REMARK 4 2Z80 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-SEP-07. REMARK 100 THE DEPOSITION ID IS D_1000027636. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 57446 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 4.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.05600 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.91 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.21200 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.52 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS-HCL PH8.5, 28% PEG2000, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.69150 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 DETAILS: AUTHOR DETERMINED BIOLOGICAL UNIT: UNKNOWN REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PRO A 2 REMARK 465 HIS A 3 REMARK 465 THR A 4 REMARK 465 LEU A 5 REMARK 465 TRP A 6 REMARK 465 MET A 7 REMARK 465 VAL A 8 REMARK 465 TRP A 9 REMARK 465 VAL A 10 REMARK 465 LEU A 11 REMARK 465 GLY A 12 REMARK 465 VAL A 13 REMARK 465 ILE A 14 REMARK 465 ILE A 15 REMARK 465 SER A 16 REMARK 465 LEU A 17 REMARK 465 SER A 18 REMARK 465 LYS A 19 REMARK 465 GLU A 20 REMARK 465 GLU A 21 REMARK 465 SER A 22 REMARK 465 SER A 23 REMARK 465 ASN A 24 REMARK 465 GLN A 25 REMARK 465 ALA A 26 REMARK 465 GLU A 241 REMARK 465 LEU A 242 REMARK 465 SER A 243 REMARK 465 THR A 244 REMARK 465 GLY A 245 REMARK 465 GLU A 246 REMARK 465 MET B 1 REMARK 465 PRO B 2 REMARK 465 HIS B 3 REMARK 465 THR B 4 REMARK 465 LEU B 5 REMARK 465 TRP B 6 REMARK 465 MET B 7 REMARK 465 VAL B 8 REMARK 465 TRP B 9 REMARK 465 VAL B 10 REMARK 465 LEU B 11 REMARK 465 GLY B 12 REMARK 465 VAL B 13 REMARK 465 ILE B 14 REMARK 465 ILE B 15 REMARK 465 SER B 16 REMARK 465 LEU B 17 REMARK 465 SER B 18 REMARK 465 LYS B 19 REMARK 465 GLU B 20 REMARK 465 GLU B 21 REMARK 465 SER B 22 REMARK 465 SER B 23 REMARK 465 ASN B 24 REMARK 465 GLN B 25 REMARK 465 ALA B 26 REMARK 465 GLU B 241 REMARK 465 LEU B 242 REMARK 465 SER B 243 REMARK 465 THR B 244 REMARK 465 GLY B 245 REMARK 465 GLU B 246 REMARK 465 THR B 247 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 39 -73.76 -35.84 REMARK 500 SER A 42 -3.87 -151.28 REMARK 500 ASN A 62 -161.04 -116.41 REMARK 500 ASN A 86 -166.89 -117.92 REMARK 500 LEU A 99 49.36 -85.53 REMARK 500 ASN A 110 -161.54 -124.00 REMARK 500 LEU A 123 48.17 -104.66 REMARK 500 PRO A 135 48.17 -72.37 REMARK 500 ASP A 231 -0.53 64.45 REMARK 500 ASN A 248 68.47 39.38 REMARK 500 LEU A 300 58.80 -92.48 REMARK 500 ASN A 330 56.73 -101.93 REMARK 500 ASN B 62 -157.94 -111.80 REMARK 500 ASN B 86 -154.97 -110.94 REMARK 500 LEU B 99 41.12 -95.27 REMARK 500 ASN B 110 -163.09 -123.94 REMARK 500 PRO B 135 29.12 -68.05 REMARK 500 ASP B 231 4.84 59.91 REMARK 500 THR B 236 -6.05 83.74 REMARK 500 CYS B 315 34.14 -95.49 REMARK 500 PRO B 318 31.67 -74.84 REMARK 500 ARG B 319 -36.18 -162.26 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2Z7X RELATED DB: PDB REMARK 900 RELATED ID: 2Z81 RELATED DB: PDB REMARK 900 RELATED ID: 2Z82 RELATED DB: PDB DBREF 2Z80 A 1 284 UNP O60603 TLR2_HUMAN 1 284 DBREF 2Z80 A 290 353 UNP Q4G1L2 Q4G1L2_EPTBU 136 199 DBREF 2Z80 B 1 284 UNP O60603 TLR2_HUMAN 1 284 DBREF 2Z80 B 290 353 UNP Q4G1L2 Q4G1L2_EPTBU 136 199 SEQADV 2Z80 SER A 285 UNP O60603 LINKER SEQADV 2Z80 ARG A 286 UNP O60603 LINKER SEQADV 2Z80 ASN A 287 UNP O60603 LINKER SEQADV 2Z80 GLN A 288 UNP O60603 LINKER SEQADV 2Z80 LEU A 289 UNP O60603 LINKER SEQADV 2Z80 SER B 285 UNP O60603 LINKER SEQADV 2Z80 ARG B 286 UNP O60603 LINKER SEQADV 2Z80 ASN B 287 UNP O60603 LINKER SEQADV 2Z80 GLN B 288 UNP O60603 LINKER SEQADV 2Z80 LEU B 289 UNP O60603 LINKER SEQRES 1 A 353 MET PRO HIS THR LEU TRP MET VAL TRP VAL LEU GLY VAL SEQRES 2 A 353 ILE ILE SER LEU SER LYS GLU GLU SER SER ASN GLN ALA SEQRES 3 A 353 SER LEU SER CYS ASP ARG ASN GLY ILE CYS LYS GLY SER SEQRES 4 A 353 SER GLY SER LEU ASN SER ILE PRO SER GLY LEU THR GLU SEQRES 5 A 353 ALA VAL LYS SER LEU ASP LEU SER ASN ASN ARG ILE THR SEQRES 6 A 353 TYR ILE SER ASN SER ASP LEU GLN ARG CYS VAL ASN LEU SEQRES 7 A 353 GLN ALA LEU VAL LEU THR SER ASN GLY ILE ASN THR ILE SEQRES 8 A 353 GLU GLU ASP SER PHE SER SER LEU GLY SER LEU GLU HIS SEQRES 9 A 353 LEU ASP LEU SER TYR ASN TYR LEU SER ASN LEU SER SER SEQRES 10 A 353 SER TRP PHE LYS PRO LEU SER SER LEU THR PHE LEU ASN SEQRES 11 A 353 LEU LEU GLY ASN PRO TYR LYS THR LEU GLY GLU THR SER SEQRES 12 A 353 LEU PHE SER HIS LEU THR LYS LEU GLN ILE LEU ARG VAL SEQRES 13 A 353 GLY ASN MET ASP THR PHE THR LYS ILE GLN ARG LYS ASP SEQRES 14 A 353 PHE ALA GLY LEU THR PHE LEU GLU GLU LEU GLU ILE ASP SEQRES 15 A 353 ALA SER ASP LEU GLN SER TYR GLU PRO LYS SER LEU LYS SEQRES 16 A 353 SER ILE GLN ASN VAL SER HIS LEU ILE LEU HIS MET LYS SEQRES 17 A 353 GLN HIS ILE LEU LEU LEU GLU ILE PHE VAL ASP VAL THR SEQRES 18 A 353 SER SER VAL GLU CYS LEU GLU LEU ARG ASP THR ASP LEU SEQRES 19 A 353 ASP THR PHE HIS PHE SER GLU LEU SER THR GLY GLU THR SEQRES 20 A 353 ASN SER LEU ILE LYS LYS PHE THR PHE ARG ASN VAL LYS SEQRES 21 A 353 ILE THR ASP GLU SER LEU PHE GLN VAL MET LYS LEU LEU SEQRES 22 A 353 ASN GLN ILE SER GLY LEU LEU GLU LEU GLU PHE SER ARG SEQRES 23 A 353 ASN GLN LEU LYS SER VAL PRO ASP GLY ILE PHE ASP ARG SEQRES 24 A 353 LEU THR SER LEU GLN LYS ILE TRP LEU HIS THR ASN PRO SEQRES 25 A 353 TRP ASP CYS SER CYS PRO ARG ILE ASP TYR LEU SER ARG SEQRES 26 A 353 TRP LEU ASN LYS ASN SER GLN LYS GLU GLN GLY SER ALA SEQRES 27 A 353 LYS CYS SER GLY SER GLY LYS PRO VAL ARG SER ILE ILE SEQRES 28 A 353 CYS PRO SEQRES 1 B 353 MET PRO HIS THR LEU TRP MET VAL TRP VAL LEU GLY VAL SEQRES 2 B 353 ILE ILE SER LEU SER LYS GLU GLU SER SER ASN GLN ALA SEQRES 3 B 353 SER LEU SER CYS ASP ARG ASN GLY ILE CYS LYS GLY SER SEQRES 4 B 353 SER GLY SER LEU ASN SER ILE PRO SER GLY LEU THR GLU SEQRES 5 B 353 ALA VAL LYS SER LEU ASP LEU SER ASN ASN ARG ILE THR SEQRES 6 B 353 TYR ILE SER ASN SER ASP LEU GLN ARG CYS VAL ASN LEU SEQRES 7 B 353 GLN ALA LEU VAL LEU THR SER ASN GLY ILE ASN THR ILE SEQRES 8 B 353 GLU GLU ASP SER PHE SER SER LEU GLY SER LEU GLU HIS SEQRES 9 B 353 LEU ASP LEU SER TYR ASN TYR LEU SER ASN LEU SER SER SEQRES 10 B 353 SER TRP PHE LYS PRO LEU SER SER LEU THR PHE LEU ASN SEQRES 11 B 353 LEU LEU GLY ASN PRO TYR LYS THR LEU GLY GLU THR SER SEQRES 12 B 353 LEU PHE SER HIS LEU THR LYS LEU GLN ILE LEU ARG VAL SEQRES 13 B 353 GLY ASN MET ASP THR PHE THR LYS ILE GLN ARG LYS ASP SEQRES 14 B 353 PHE ALA GLY LEU THR PHE LEU GLU GLU LEU GLU ILE ASP SEQRES 15 B 353 ALA SER ASP LEU GLN SER TYR GLU PRO LYS SER LEU LYS SEQRES 16 B 353 SER ILE GLN ASN VAL SER HIS LEU ILE LEU HIS MET LYS SEQRES 17 B 353 GLN HIS ILE LEU LEU LEU GLU ILE PHE VAL ASP VAL THR SEQRES 18 B 353 SER SER VAL GLU CYS LEU GLU LEU ARG ASP THR ASP LEU SEQRES 19 B 353 ASP THR PHE HIS PHE SER GLU LEU SER THR GLY GLU THR SEQRES 20 B 353 ASN SER LEU ILE LYS LYS PHE THR PHE ARG ASN VAL LYS SEQRES 21 B 353 ILE THR ASP GLU SER LEU PHE GLN VAL MET LYS LEU LEU SEQRES 22 B 353 ASN GLN ILE SER GLY LEU LEU GLU LEU GLU PHE SER ARG SEQRES 23 B 353 ASN GLN LEU LYS SER VAL PRO ASP GLY ILE PHE ASP ARG SEQRES 24 B 353 LEU THR SER LEU GLN LYS ILE TRP LEU HIS THR ASN PRO SEQRES 25 B 353 TRP ASP CYS SER CYS PRO ARG ILE ASP TYR LEU SER ARG SEQRES 26 B 353 TRP LEU ASN LYS ASN SER GLN LYS GLU GLN GLY SER ALA SEQRES 27 B 353 LYS CYS SER GLY SER GLY LYS PRO VAL ARG SER ILE ILE SEQRES 28 B 353 CYS PRO MODRES 2Z80 ASN A 114 ASN GLYCOSYLATION SITE HET NAG A 801 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE FORMUL 3 NAG C8 H15 N O6 FORMUL 4 HOH *263(H2 O) HELIX 1 1 SER A 116 LYS A 121 1 6 HELIX 2 2 LEU A 212 THR A 221 1 10 HELIX 3 3 THR A 262 GLN A 275 1 14 HELIX 4 4 SER A 316 ASN A 330 1 15 HELIX 5 5 PRO A 346 ILE A 350 5 5 HELIX 6 6 SER B 116 LYS B 121 1 6 HELIX 7 7 LEU B 212 THR B 221 1 10 HELIX 8 8 THR B 262 GLN B 275 1 14 HELIX 9 9 SER B 316 ASN B 330 1 15 HELIX 10 10 PRO B 346 ILE B 350 5 5 SHEET 1 A14 SER A 29 CYS A 30 0 SHEET 2 A14 ILE A 35 LYS A 37 -1 O LYS A 37 N SER A 29 SHEET 3 A14 SER A 56 ASP A 58 1 O SER A 56 N CYS A 36 SHEET 4 A14 ALA A 80 VAL A 82 1 O VAL A 82 N LEU A 57 SHEET 5 A14 HIS A 104 ASP A 106 1 O HIS A 104 N LEU A 81 SHEET 6 A14 PHE A 128 ASN A 130 1 O PHE A 128 N LEU A 105 SHEET 7 A14 ILE A 153 ASN A 158 1 O ILE A 153 N LEU A 129 SHEET 8 A14 PHE A 175 ALA A 183 1 O GLU A 180 N LEU A 154 SHEET 9 A14 ASN A 199 HIS A 206 1 O ILE A 204 N ILE A 181 SHEET 10 A14 VAL A 224 ARG A 230 1 O GLU A 228 N LEU A 205 SHEET 11 A14 LYS A 253 ARG A 257 1 O THR A 255 N LEU A 227 SHEET 12 A14 GLU A 281 GLU A 283 1 O GLU A 283 N PHE A 256 SHEET 13 A14 LYS A 305 TRP A 307 1 O TRP A 307 N LEU A 282 SHEET 14 A14 GLU A 334 GLN A 335 1 O GLN A 335 N ILE A 306 SHEET 1 B 2 TYR A 66 ILE A 67 0 SHEET 2 B 2 THR A 90 ILE A 91 1 O THR A 90 N ILE A 67 SHEET 1 C 2 LYS A 164 ILE A 165 0 SHEET 2 C 2 SER A 188 TYR A 189 1 O SER A 188 N ILE A 165 SHEET 1 D14 SER B 29 CYS B 30 0 SHEET 2 D14 ILE B 35 LYS B 37 -1 O LYS B 37 N SER B 29 SHEET 3 D14 SER B 56 ASP B 58 1 O SER B 56 N CYS B 36 SHEET 4 D14 ALA B 80 VAL B 82 1 O VAL B 82 N LEU B 57 SHEET 5 D14 HIS B 104 ASP B 106 1 O HIS B 104 N LEU B 81 SHEET 6 D14 PHE B 128 ASN B 130 1 O ASN B 130 N LEU B 105 SHEET 7 D14 ILE B 153 GLY B 157 1 O ARG B 155 N LEU B 129 SHEET 8 D14 PHE B 175 ASP B 182 1 O GLU B 180 N VAL B 156 SHEET 9 D14 ASN B 199 HIS B 206 1 O ILE B 204 N ILE B 181 SHEET 10 D14 VAL B 224 ARG B 230 1 O GLU B 228 N LEU B 205 SHEET 11 D14 LYS B 253 ARG B 257 1 O THR B 255 N LEU B 229 SHEET 12 D14 GLU B 281 GLU B 283 1 O GLU B 283 N PHE B 256 SHEET 13 D14 LYS B 305 TRP B 307 1 O TRP B 307 N LEU B 282 SHEET 14 D14 GLU B 334 GLN B 335 1 O GLN B 335 N ILE B 306 SHEET 1 E 2 TYR B 66 ILE B 67 0 SHEET 2 E 2 THR B 90 ILE B 91 1 O THR B 90 N ILE B 67 SHEET 1 F 2 LYS B 164 ILE B 165 0 SHEET 2 F 2 SER B 188 TYR B 189 1 O SER B 188 N ILE B 165 SSBOND 1 CYS A 30 CYS A 36 1555 1555 2.04 SSBOND 2 CYS A 315 CYS A 340 1555 1555 2.03 SSBOND 3 CYS A 317 CYS A 352 1555 1555 2.04 SSBOND 4 CYS B 30 CYS B 36 1555 1555 2.04 SSBOND 5 CYS B 315 CYS B 340 1555 1555 2.03 SSBOND 6 CYS B 317 CYS B 352 1555 1555 2.03 LINK ND2 ASN A 114 C1 NAG A 801 1555 1555 1.45 CRYST1 54.269 101.383 59.586 90.00 99.82 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018427 0.000000 0.003189 0.00000 SCALE2 0.000000 0.009864 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017032 0.00000